We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
IL28B Is Associated with Outcomes of Chronic HBV Infection.
- Authors
Xiaodong Shi; Xiumei Chi; Yu Pan; Yanhang Gao; Wanyu Li; Chen Yang; Jin Zhong; Damo Xu; Manna Zhang; Gerald Minuk; Jing Jiang; Junqi Niu
- Abstract
Purpose: The role of IL28B gene variants and expression in hepatitis B virus (HBV) infections are not well understood. Here, we evaluated whether IL28B gene expression and rs12979860 variations are associated with HBV outcomes. Materials and Methods: IL28B genetic variations (rs12979860) were genotyped by pyrosequencing of DNA samples from 137 individuals with chronic HBV infection [50 inactive carriers (IC), 34 chronic hepatitis B (CHB), 27 cirrhosis, 26 hepatocellular carcinoma (HCC)], and 19 healthy controls. IL28A/B mRNA expression in peripheral blood mononuclear cells was determined by qRT-PCR, and serum IL28B protein was measured by ELISA. Results: Patients with IL28B C/C genotype had greater IL28A/B mRNA expression and higher IL28B protein levels than C/T patients. Within the various disease stages, compared to IC and healthy controls, IL28B expression was reduced in the CHB, cirrhosis, and HCC cohorts (CHB vs. IC, p=0.02; cirrhosis vs. IC, p=0.01; HCC vs. IC, p=0.001; CHB vs. controls, p<0.01; cirrhosis vs. controls, p<0.01; HCC vs. controls, p<0.01). When stratified with respect to serum HBV markers in the IC and CHB cohorts, IL28B mRNA and protein levels were higher in HBeAg-positive than negative individuals (p=0.01). Logistic regression analysis revealed that factors associated with high IL28B protein levels were C/C versus C/T genotype [p=0.016, odds ratio (OR)=0.25, 95% confidence interval (CI)=0.08-0.78], high alanine aminotransferase values (p<0.001, OR=8.02, 95% CI=2.64-24.4), and the IC stage of HBV infection (p<0.001). Conclusion: Our data suggest that IL28B genetic variations may play an important role in long-term development of disease in chronic HBV infections.
- Subjects
CHRONIC hepatitis B; INTERLEUKINS; HEALTH outcome assessment; GENE expression in viruses; HUMAN genetic variation; LIVER cancer; MONONUCLEAR leukocytes
- Publication
Yonsei Medical Journal, 2015, Vol 56, Issue 3, p625
- ISSN
0513-5796
- Publication type
Article
- DOI
10.3349/ymj.2015.56.3.625